不同剂量腺苷蛋氨酸对病毒性肝炎患者的治疗效果

Effects of Different Amounts of Adenosine Methionine on Patients With Viral Hepatitis

目的分析在病毒性肝炎患者的治疗中使用不同剂量腺苷蛋氨酸治疗之后患者病情和肝内胆汁淤积的改善情况。方法将2013年1月—2014年1月的68例病毒性肝炎患者作为研究对象。将参与研究的患者随机分成实验组(34例)和对照组(34例),对照组治疗过程中对患者使用每天一次量为1 000毫克的腺苷蛋氨酸治疗,实验组则在对照组的基础上增加1 000毫克剂量治疗。结果参与本次研究之后,实验组在病情和肝内胆汁淤积的改善情况方面优于对照组(P <0.05)。研究之后的数据具有统计学意义。结论病毒性肝炎患者在使用每天一次量为2 000毫克的腺苷蛋氨酸治疗之后患者病情得到改善,肝内胆汁淤积也得到缓解,说明每天一次量为2 000毫克的腺苷蛋氨酸在病毒性肝炎患者的治疗上具有意义。

Objective To analyze the improvement of the disease condition and antipathetic cholesterol after the treatment with different doses of adenine boniness.Methods A total of 68 cases of viral hepatitis were studied from January 2013 to January 2014.The patients in the study were randomly divided into the experimental group(34 cases)and the control group(34 cases).During the treatment of the control group,the patients were treated with adenine boniness once a day,which was 1 000 mg.Results After participating in this study,the experimental group was superior to the control group in terms of the disease condition and improvement of antipathetic cholesterol(P<0.05).The data after the study were statistically significant.Conclusion Patients with viral hepatitis experienced significant improvement in their condition after treatment with 2 000 mg of adenine boniness once a day,as well as significant remission of antipathetic cholesterol,suggesting that 2 000 mg of adenine boniness once a day is of widespread value in the treatment of patients with viral hepatitis.